Detalhe da pesquisa
1.
Achieving white blood cell equity: are the safety profiles of biosimilar and reference pegfilgrastims comparable?
Future Oncol
; 20(3): 145-158, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37609795
2.
Novel Tumor Growth Rate Analysis in the Randomized CLARINET Study Establishes the Efficacy of Lanreotide Depot/Autogel 120 mg with Prolonged Administration in Indolent Neuroendocrine Tumors.
Oncologist
; 26(4): e632-e638, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33393112
3.
Use of Molecular Assays and Circulating Tumor DNA in Early-Stage Colorectal Cancer: A Roundtable Discussion of the Gastrointestinal Cancer Therapy Expert Group.
Oncologist
; 26(8): 651-659, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33650740
4.
Clinicopathogenomic analysis of mismatch repair proficient colorectal adenocarcinoma uncovers novel prognostic subgroups with differing patterns of genetic evolution.
Int J Cancer
; 139(7): 1546-56, 2016 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27194209
5.
Full dose neoadjuvant FOLFIRINOX is associated with prolonged survival in patients with locally advanced pancreatic adenocarcinoma.
Pancreatology
; 15(6): 667-73, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26412296
6.
Percutaneous irreversible electroporation for the treatment of colorectal cancer liver metastases with a proposal for a new response evaluation system.
J Vasc Interv Radiol
; 25(8): 1233-1239.e2, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24861662
7.
A retrospective study of neoadjuvant FOLFIRINOX in unresectable or borderline-resectable locally advanced pancreatic adenocarcinoma.
BMC Cancer
; 12: 199, 2012 May 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-22642850
8.
Novel approaches for myelodysplastic syndromes: beyond hypomethylating agents.
Curr Opin Hematol
; 17(2): 104-9, 2010 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-20178141
9.
Clinical and treatment characteristics of patients treated with the first therapeutic oncology biosimilars bevacizumab-awwb and trastuzumab-anns in the US.
Ther Adv Med Oncol
; 13: 17588359211041961, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-35003333
10.
Concurrent Nab-paclitaxel and Radiotherapy: Novel Radiosensitization for Borderline Resectable or Unresectable Pancreatic Cancer.
Am J Clin Oncol
; 44(9): 469-474, 2021 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34310350
11.
A phase 2 study of vorinostat in acute myeloid leukemia.
Haematologica
; 94(10): 1375-82, 2009 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-19794082
12.
Effect of Gemcitabine and nab-Paclitaxel With or Without Hydroxychloroquine on Patients With Advanced Pancreatic Cancer: A Phase 2 Randomized Clinical Trial.
JAMA Oncol
; 5(7): 993-998, 2019 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31120501
13.
Differences in overall survival and mutation prevalence between right- and left-sided colorectal adenocarcinoma.
J Gastrointest Oncol
; 9(5): 778-784, 2018 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-30505575
14.
Cardiotoxicity: Myocardium or Endothelium.
Cureus
; 10(7): e2994, 2018 Jul 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-30245948
15.
A KRAS wild type mutational status confers a survival advantage in pancreatic ductal adenocarcinoma.
J Gastrointest Oncol
; 9(1): 1-10, 2018 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-29564165
16.
Neoadjuvant Nab-paclitaxel and Gemcitabine in Borderline Resectable or Locally Advanced Unresectable Pancreatic Adenocarcinoma in Patients Who Are Ineligible for FOLFIRINOX.
Anticancer Res
; 38(7): 4035-4039, 2018 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-29970528
17.
A phase I dose escalation trial of nab-paclitaxel and fixed dose radiation in patients with unresectable or borderline resectable pancreatic cancer.
Cancer Chemother Pharmacol
; 81(3): 609-614, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29362902
18.
Somatostatin Receptor Avidity in Gastrointestinal Stromal Tumors: Theranostic Implications of Gallium-68 Scan and Eligibility for Peptide Receptor Radionuclide Therapy.
Cureus
; 9(9): e1710, 2017 Sep 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-29188154
19.
The Role of Biosimilars in Patient Access to Therapeutic Antibodies for Immune Mediated Inflammatory Diseases.
Curr Pharm Des
; 23(44): 6779-6783, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-29189136
20.
Cardio-Oncology: Cancer Therapy-related Cardiovascular Complications in a Molecular Targeted Era: New Concepts and Perspectives.
Cureus
; 9(5): e1258, 2017 May 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-28649481